U.S. cell line development market held largest market share of USD 1.0 billion in 2017 owing to growing reimbursements from public and private insurers, presence of sophisticated healthcare facilities.

Pune, Maharashtra -- (SBWire) -- 03/18/2019 --The Graphical Research report titled "North America Cell Line Development Market" that represents the broad information comprising methodology and scope, industry insights, growth drivers, applications insights, company profiles and industry background, business trends, porter's analysis, pestel analysis, product landscape, swot analysis to 2024.

"North America Cell Line Development Market based on Cell Line, Product, Source, Application, Application Potential, Industry Analysis Report, Regional Outlook, Competitive Market Share & Forecast, 2018 - 2024", estimated to cross USD 2.7 billion by 2024.

Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of cancer incidences will drive North America cell line development market. Rising vaccine production, growth of biotechnology industry and high healthcare expenditure will drive business growth.

Get sample of this research report @ https://www.graphicalresearch.com/request/1067/sample

Reagent and media product segment accounted for largest market share in 2017 and is estimated to follow similar trend over the coming years due to its numerous applications in development of regenerative medicines, bio production, drug discovery, tissue engineering toxicity testing and research.

Presence of dominant industry players in U.S. focusing on developing advanced cell line development products coupled with favorable regulatory structure and innovation in development of biologics due to patent expiration will drive North America cell line development market. However, concerns pertaining to stem cell research will hinder industry growth over the forecast timeframe.

Non-mammalian source segment will witness considerable growth during the forecast period owing to its noteworthy applications in insecticide screening and toxicology study.

Make an inquiry for buying this report @https://www.graphicalresearch.com/request/1067/inquiry-before-buying

Hybridomas cell line type segment is forecasted to witness robust growth during the forecast timeframe. Hybridoma technology is most widely used process for large scale production of monoclonal antibodies. The success of monoclonal antibodies in improving quality of life in patients suffering from cancer, autoimmune diseases and anti-inflammatory disorders have led to increased R&D for developing monoclonal antibodies for various critical health conditions will positively impact growth of cell line development market.

Canada cell line development market will grow considerably during the forecast period owing to numerous efforts undertaken by Canadian government to advance stem cell research and development of stable cell lines for bioproduction in the country. Growing awareness about cell-based therapy, innovation in development of biologics and rising prevalence of cancer will stimulate growth of Canada cell line development market.

Key industry players operating in North America cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXi AppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy. Industry players are adopting strategies including merger, acquisition and strategic collaboration and partnership to expand their product portfolio as well as augment consumer base in the industry.

Browse full report @
https://www.graphicalresearch.com/industry-insights/1067/north-america-cell-line-development-market

Segments we Covered in this Report:

North America Cell Line Development Market, by application, 2013-2024
- Bioproduction market
- Drug discovery
- Toxicity testing
- Tissue engineering
- Research

North America Cell Line Development Market, by product, 2013-2024
- Reagents & media
- Equipment
- Accessories & consumables

North America Cell Line Development Market, by source, 2013-2024
- Mammalian
- Non-mammalian

North America Cell Line Development Market, by cell line type, 2013-2024
- Recombinant cell lines
- Hybridomas
- Continuous cell lines
- Primary cell lines

The above information is provided for the following countries:
- U.S.
- Canada

About Graphical Research
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.